Catalyst Wire Dossier Catalyst Wire Dossier

OJJAARA

MOMELOTINIB · GlaxoSmithKline LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for OJJAARA, covering 2023-09-15 to 2026-03-18. Get the full timeline:

Most recent: FDA Approved: OJJAARA — Supplemental Application (GlaxoSmithKline LLC)

See pricing